Massachusetts Medical Society

SHERPA: Blue

People

  1. Motzer
    Motzer
  2. Zauber
    Zauber
  3. Offit
    Offit
  4. Winawer
    Winawer
  5. Hudis
    Hudis
  6. Postow
    Postow
  7. Sepkowitz
    Sepkowitz
  8. Ladanyi
    Ladanyi
  9. Norton
    Norton
  10. Robson
    Robson

Groups

  1. Department of Medicine (327)
  2. Solid Tumor Oncology Division (209)
  3. GSK Faculty (112)
  4. Hematologic Malignancies, Division of (86)
  5. Center for Hematologic Malignancies (84)
  6. Population Sciences Research Program (80)
  7. Survivorship Research (76)
  8. Epidemiology and Biostatistics (65)
  9. Surgery (64)
  10. Sloan Kettering Institute Faculty (58)
Search Within
Formats
  1. Journal Article (517)
  2. Correspondence (27)
  3. Editorial (23)
  4. Research Letter (8)
  5. Review (4)
Groups
  1. Department of Medicine (327)
  2. Solid Tumor Oncology Division (209)
  3. GSK Faculty (112)
  4. Hematologic Malignancies, Division of (86)
  5. Center for Hematologic Malignancies (84)
  6. Population Sciences Research Program (80)

More Groups

People
  1. Robert Motzer (25)
  2. Jedd Wolchok (22)
  3. Peter Bach (18)
  4. Ann Zauber (15)
  5. Kenneth Offit (14)
  6. Sidney Winawer (14)

More People

Years
  1. 2025 (13)
  2. 2024 (16)
  3. 2023 (31)
  4. 2022 (27)
  5. 2021 (24)
  6. 2020 (14)

More Years

Publications
  1. New England Journal of Medicine (574)
  2. NEJM Evidence (4)
  3. Cellular Therapy and Transplantation (1)

Results (579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma
    Journal Article

    Choueiri, T. K.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Zurawski, B.; Oyervides Juárez, V. M.; Hsieh, J. J.; Basso, U.; Shah, A. Y.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Shedding of viable SARS-COV-2 after immunosuppressive therapy for cancer
    Research Letter

    Aydillo, T.; Gonzalez-Reiche, A. S.; Aslam, S.; van de Guchte, A.; Khan, Z.; Obla, A.; Dutta, J.; van Bakel, H.; Aberg, J.; García-Sastre, A.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Pembrolizumab in microsatellite-instability-high advanced colorectal cancer
    Journal Article

    André, T.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C.; Smith, D.; Garcia-Carbonero, R.; Benavides, M.; Gibbs, P.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • KRAS(G12C) inhibition with sotorasib in advanced solid tumors
    Journal Article

    Hong, D. S.; Fakih, M. G.; Strickler, J. H.; Desai, J.; Durm, G. A.; Shapiro, G. I.; Falchook, G. S.; Price, T. J.; Sacher, A.; Denlinger, C. S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations
    Journal Article

    Paik, P. K.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Garassino, M. C.; Mazieres, J.; Viteri, S.; Senellart, H.; Van Meerbeeck, J.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Racial differences in genomic profiling of prostate cancer - To the editor
    Research Letter

    Mahal, B. A.; Alshalalfa, M.; Kensler, K. H.; Chowdhury-Paulino, I.; Kantoff, P.; Mucci, L. A.; Schaeffer, E. M.; Spratt, D.; Yamoah, K.; Nguyen, P. L.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET-altered thyroid cancers
    Journal Article

    Wirth, L. J.; Sherman, E.; Robinson, B.; Solomon, B.; Kang, H.; Lorch, J.; Worden, F.; Brose, M.; Patel, J.; Leboulleux, S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Johnson, M.; Gainor, J.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Microbiota and allogeneic hematopoietic-cell transplantation: The authors reply
    Correspondence

    Peled, J. U.; Gomes, A. L. C.; van den Brink, M. R. M.
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Asciminib in relapsed chronic myeloid leukemia - The authors reply
    Correspondence

    Mauro, M. J.; Hughes, T. P.
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save